Stepan VP granted RSUs, perf shares and SARs
Stepan Co vice president, general counsel and secretary Shawn G. Lisle reported multiple equity awards.
Rhea-AI Filing Summary
Stepan Co vice president, general counsel and secretary Shawn G. Lisle reported multiple equity awards. On March 2, 2026, he received 4,495 restricted stock units, 2,247 performance shares and 6,440 stock appreciation rights, all as grants with no cash paid. On February 27, 2026, he also acquired 25.544 shares of common stock at $52.51 per share as an award. The RSUs vest in equal portions over three years, while the performance shares vest if Stepan meets specified performance goals for a period ending on December 31, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 4,495 | $0.00 | $0.00 |
| Grant/Award | Performance Shares | 2,247 | $0.00 | $0.00 |
| Grant/Award | Stock Appreciation Right | 6,440 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 25.544 | $52.51 | $1K |
Footnotes (4)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
- F2. Vest ratably over three years beginning on the date shown.
- F3. Each performance share represents a contingent right to receive one share of Stepan Company common stock.
- F4. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SCL executive Shawn G. Lisle report?
How many restricted stock units did SCL grant to Shawn G. Lisle?
What stock appreciation rights were granted to the SCL executive in this Form 4?
Did Shawn G. Lisle buy or sell SCL common stock in the open market?
How do the SCL restricted stock units for Shawn G. Lisle vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.